Role of furosemide therapy after booster-packed erythrocyte transfusions in infants with bronchopulmonary dysplasia.
Stefano
J L
JL
Medical Center of Delaware, Division of Neonatology, Newark 19718.
Bhutani
V K
VK
D000284:Administration, Oral; D001803:Blood Transfusion / Q000379:methods / Q000592:standards*; D001997:Bronchopulmonary Dysplasia / Q000188:drug therapy* / Q000503:physiopathology / Q000628:therapy; D017707:Erythrocyte Transfusion; D005665:Furosemide / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D007275:Injections, Intravenous; D008170:Lung Compliance / Q000187:drug effects; D010101:Oxygen Consumption; D013990:Tidal Volume / Q000187:drug effects; D065227:Transfusion Reaction
D005665:Furosemide